Obstetric and perinatal risks after new coronavirus infection

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: Numerous studies indicate that pregnant women are at risk for severe morbidity, adverse gestational outcomes, and mortality following COVID-19. These patients have a higher frequency of miscarriage at various stages of gestation, premature birth, preeclampsia, cesarean section, and birth of children with low body weight. Other publications have suggested that the clinical characteristics of the disease detected in pregnant women with confirmed COVID-19 are similar to those in the general population.

AIM: The aim of this study was to determine obstetric and perinatal risks in women who have had COVID-19 during pregnancy.

MATERIALS AND METHODS: We conducted an open prospective continuous cross-sectional study in which 114 patients were examined after suffering from COVID-19. Depending on the severity of the new coronavirus infection, they were divided into groups: group I (n = 36) included patients with mild disease, group II (n = 56) – with moderate disease, group III (n = 22) – with heavy. The control group consisted of 93 pregnant women who were hospitalized during the specified period without COVID-19 and signs of acute respiratory viral infection.

RESULTS: Gestational diabetes mellitus is associated with a risk of the moderate and severe new coronavirus infections during pregnancy. Placental deficiency is significantly more often recorded in moderate and severe COVID-19 cases. Severe COVID-19 in pregnant women determines a high probability of fetal growth restriction. Preeclampsia complicates pregnancy in all patients with either mild, moderate, or severe COVID-19. The risk of premature birth with a high probability is determined by the moderate and severe courses of the disease. Only moderate COVID-19 during pregnancy is associated with the risk of induced labor. The risk of operative delivery by cesarean section is significantly increased in moderate and severe COVID-19. Moderate and severe courses of the underlying disease during pregnancy determine a high probability of low body weight of children at birth. The risk of hospitalization in the resuscitation unit is associated with moderate and severe COVID-19 during pregnancy.

CONCLUSIONS: Maternal mortality among women with COVID-19 who were hospitalized in an obstetric hospital was 3,636 per 100,000 live births. Perinatal mortality in patients who suffered a new coronavirus infection during pregnancy was 52.6‰.

Full Text

Restricted Access

About the authors

Irina V. Medyannikova

Omsk State Medical University

Email: mediren@gmail.com
ORCID iD: 0000-0001-6892-2800

MD, Dr. Sci. (Med.), Assistant Professor

Russian Federation, Omsk

Yulia Ch. Kuklis

Infectious Disease Clinical Hospital No. 2

Email: miss.kuklis@mail.ru
ORCID iD: 0000-0003-4155-0597

MD

Russian Federation, Moscow

Irina V. Savelyeva

Omsk State Medical University

Email: savelyeva_iv_omsk@mail.ru
ORCID iD: 0000-0001-9342-7342

MD, Dr. Sci. (Med.), Assistant Professor

Russian Federation, Omsk

Galina B. Beznoshchenko

Omsk State Medical University

Email: akusheromsk@rambler.ru
ORCID iD: 0000-0002-6795-1607

MD, Dr. Sci. (Med.), Professor

Russian Federation, Omsk

Elena G. Galyanskaya

Omsk State Medical University

Email: galaynskaya@mail.ru
ORCID iD: 0000-0002-9603-7363

MD, Cand. Sci. (Med.)

Russian Federation, Omsk

Olga Yu. Tsygankova

Omsk State Medical University

Email: olts74@mail.ru
ORCID iD: 0000-0002-3553-055X

MD, Cand. Sci. (Med.)

Russian Federation, Omsk

Evgeny G. Prodanchuk

Omsk State Medical University

Email: ompeg@mail.ru
ORCID iD: 0000-0003-4498-5836

MD, Cand. Sci. (Med.)

Russian Federation, Omsk

Elena A. Bukharova

Omsk State Medical University

Email: buxarova88@mail.ru
ORCID iD: 0000-0002-6093-3721

MD

Russian Federation, Omsk

Natalya V. Nosova

Omsk State Medical University

Email: natalya-nosova-85@mail.ru
ORCID iD: 0000-0002-2362-5367

MD

Russian Federation, Omsk

Pavel V. Davydov

Omsk State Medical University

Author for correspondence.
Email: pavada2@mail.ru
ORCID iD: 0000-0001-6867-7024

MD

Russian Federation, Omsk

References

  1. Schwartz DA, Graham AL. Potential maternal and infant outcomes from (Wuhan) Coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses. 2020;12(2):194. doi: 10.3390/v12020194
  2. Liu H, Wang LL, Zhao SJ, et al. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. J Reprod Immunol. 2020;139. doi: 10.1016/j.jri.2020.103122
  3. Westgren M, Pettersson K, Hagberg H, et al. Severe maternal morbidity and mortality associated with COVID-19: the risk should not be downplayed. Acta Obstet Gynecol Scand. 2020;99(7):815–816. doi: 10.1111/aogs.13900
  4. Khan MA, Khan N, Mustagir G, et al. COVID-19 infection during pregnancy: a systematic review to summarize possible symptoms, treatments, and pregnancy outcomes. medRxiv. 2020. doi: 10.1101/2020.03.31.20049304
  5. Yan J, Guo J, Fan C, et al. Coronavirus disease 2019 in pregnant women: a report based on 116 cases. Am J Obstet Gynecol. 2020;223(1):111.e1–111.e14. doi: 10.1016/j.ajog.2020.04.014
  6. Chen L, Li Q, Zheng D, et al. Clinical characteristics of pregnant women with Covid-19 in Wuhan, China. N Engl J Med. 2020;382(25):e100. doi: 10.1056/NEJMc2009226
  7. Gregg WE, Brown AA. Cognitive and physical disabilities and aging-related complications of diabetes. Clin Diabetes. 2003;21(3):113–118. doi: 10.2337/diaclin.21.3.113
  8. Priputnevich TV, Achkasova EN, Chubarov VV, Gordeev AB. Acute respiratory diseases and influenza in modern obstetrics: epidemiological features and diagnostic problems: literature review. epidemiology and vaccinal prevention. 2019;18(3):89–97. (In Russ.) doi: 10.31631/2073-3046-2019-18-3-89-97
  9. Malik A, El Masry KM, Ravi M, et al. Middle east respiratory syndrome coronavirus during pregnancy, Abu Dhabi, United Arab Emirates, 2013. Emerg Infect Dis. 2016;22(3):515–517. doi: 10.3201/eid2203.151049
  10. Mathad JS, Gupta A. Pulmonary Infections in pregnancy. Semin Respir Crit Care Med. 2017;38(2):174–184. doi: 10.1055/s-0037-1602375
  11. Bezhenar VF, Zazerskaya IE, Bettikher OA, et al. Controversial issues in obstetric management of women with novel coronavirus disease COVID-19 during pregnancy and childbirth. Obstetrics and Gynecology. 2020;(5):13–21. doi: 10.18565/aig.2020.5.13-21
  12. Priputnevich TV, Gordeev AB, Lyubasovskaya LA, et al. The novel coronavirus SARS-COV-2 and pregnancy: literature review. Obstetrics and Gynecology. 2020;(5):6–12. (In Russ.) doi: 10.18565/aig.2020.5.6-12
  13. Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809–815. doi: 10.1016/S0140-6736(20)30360-3
  14. Tam PCK, Ly KM, Kernich ML, et al. Detectable severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2021;72(1):128–130. doi: 10.1093/cid/ciaa673
  15. Novoa RH, Quintana W, Llancarí P, et al. Maternal clinical characteristics and perinatal outcomes among pregnant women with coronavirus disease 2019. A systematic review. Travel Med Infect Dis. 2021;39. doi: 10.1016/j.tmaid.2020.101919
  16. Diriba K, Awulachew E, Getu E. The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis. Eur J Med Res. 2020;25(1):39. doi: 10.1186/s40001-020-00439-w
  17. Belokrinitskaya TE, Artymuk NV, Filippov OS, et al. Clinical course, maternal and perinatal outcomes of 2019 novel coronavirus infectious disease (COVID-19) in pregnant women in Siberia and Far East. Obstetrics and Gynecology. 2021;(2):48–54. (In Russ.) doi: 10.18565/aig.202L2.48-54
  18. Jafari M, Pormohammad A, Sheikh Neshin SA, et al. Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: a systematic review and meta-analysis. Rev Med Virol. 2021;31(5):1–16. doi: 10.1002/rmv.2208
  19. Stow LR, Jacobs ME, Wingo CS, et al. Endothelin-1 gene regulation. FASEB J. 2011;25(1):16–28. doi: 10.1096/fj.10-161612
  20. Karakus S, Bozoklu Akkar O, Yildiz C, et al. Serum levels of ET-1, M30, and angiopoietins-1 and -2 in HELLP syndrome and preeclampsia compared to controls. Arch Gynecol Obstet. 2016;293(2):351–359. doi: 10.1007/s00404-015-3803-1
  21. Zdravookhranenie v Rossii. 2019: statisticheskiy sbornik / Rosstat. Moscow; 2019. (In Russ.) [cited 2023 May 20]. Available from: https://rosstat.gov.ru/storage/mediabank/Zdravoohran-2019.pdf
  22. Vallejo V, Ilagan JG. A Postpartum death due to coronavirus disease 2019 (COVID-19) in the United States. Obstet Gynecol. 2020;136(1):52–55. doi: 10.1097/AOG.0000000000003950
  23. Lokken EM, Walker CL, Delaney S, et al. Clinical characteristics of 46 pregnant women with a severe acute respiratory syndrome coronavirus 2 infection in Washington State. Am J Obstet Gynecol. 2020;223(6):911.e1–911.e14. doi: 10.1016/j.ajog.2020.05.031
  24. De Jong A, Chanques G, Jaber S. Mechanical ventilation in obese ICU patients: from intubation to extubation. Crit Care. 2017;21(1):63. doi: 10.1186/s13054-017-1641-1
  25. Ouchi N, Parker JL, Lugus JJ, et al. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85–97. doi: 10.1038/nri2921
  26. Koumoutsea EV, Vivanti AJ, Shehata N, et al. COVID-19 and acute coagulopathy in pregnancy. J Thromb Haemost. 2020;18(7):1648–1652. doi: 10.1111/jth.14856
  27. Liu D, Li L, Wu X, et al. Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis. AJR Am J Roentgenol. 2020;215(1):127–132. doi: 10.2214/AJR.20.23072
  28. Davidova YuV, Limanskaya AYu. The safety of use of interferon preparations in the treatment of acute respiratory viral infections in high risk pregnant women. Perinatologiya i Pediatriya. 2016;1(65):27–32. (In Russ.) doi: 10.15574/PP.2016.65.27
  29. Di Mascio D, Khalil A, Saccone G, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020;2(2). doi: 10.1016/j.ajogmf.2020.100107

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Figure. Obstetric and perinatal risks after new coronavirus infection

Download (326KB)

Copyright (c) 2023 Eсо-Vector

License URL: https://eco-vector.com/for_authors.php#07

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 66759 от 08.08.2016 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия Эл № 77 - 6389
от 15.07.2002 г.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies